Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease.
about
Growth hormone (GH)-dependent expression of a natural antisense transcript induces zinc finger E-box-binding homeobox 2 (ZEB2) in the glomerular podocyte: a novel action of gh with implications for the pathogenesis of diabetic nephropathyEpithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?Dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathy.Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy.High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen speciesTGF-β-activated kinase 1 is crucial in podocyte differentiation and glomerular capillary formation.Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.EGF receptor deletion in podocytes attenuates diabetic nephropathy.Alteration of vitamin D metabolic enzyme expression and calcium transporter abundance in kidney involved in type 1 diabetes-induced bone lossNew insights into epithelial-mesenchymal transition in kidney fibrosis.DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study.Relationship between urinary podocytes and kidney diseases.Podocyte dedifferentiation: a specialized process for a specialized cell.Renin-angiotensin system within the diabetic podocyte.Exosomes from high glucose-treated glomerular endothelial cells trigger the epithelial-mesenchymal transition and dysfunction of podocytesCTGF mediates high-glucose induced epithelial-mesenchymal transition through activation of β-catenin in podocytes.The roles of connective tissue growth factor and integrin-linked kinase in high glucose-induced phenotypic alterations of podocytes.Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.Advanced oxidation protein products induce apoptosis in podocytes through induction of endoplasmic reticulum stress.Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy.mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice.An overview of molecular mechanism of nephrotic syndrome.Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.Eucalyptol ameliorates Snail1/β-catenin-dependent diabetic disjunction of renal tubular epithelial cells and tubulointerstitial fibrosis.Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.A vital role for myosin-9 in puromycin aminonucleoside-induced podocyte injury by affecting actin cytoskeleton.miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.Podocyte-specific Rac1 deficiency ameliorates podocyte damage and proteinuria in STZ-induced diabetic nephropathy in mice.Diabetes induces fibrotic changes in the lung through the activation of TGF-β signaling pathways
P2860
Q24634127-2BCFB194-71A9-4511-A598-9FE712EB4A16Q26782283-7E96FEA2-97B6-477E-BCF2-AA7DFA6C4719Q30501075-696AD8FF-B21D-49F3-A1E7-528625A1D63EQ33926992-8ADB2AC9-C0A5-4CCC-864A-8A12D38DB6D2Q34053587-08A73A43-A38A-47D1-A8FB-BCD27D22F617Q34103389-3E77837F-F54A-4357-BAB5-6F9297DCC989Q34729973-6EDFBB59-FEAF-4FB8-9631-9B115149081DQ35076442-94122209-3002-4E9B-B4EB-8ABF59F17D5AQ35465168-CF2B81C3-4E5C-4C7F-A366-F378527F70DCQ35550573-C71CE5B8-8047-4C3B-9C84-85BF89804B85Q35955946-1ABF8F8D-2DCD-4CD4-92EC-59B749F5AA56Q36010095-548F334B-15C5-4C37-9ECF-C5677F6824E0Q37668895-B75F892D-6124-4940-9FC4-B1B42BEB83B6Q37976448-A1C6B442-68BE-49A6-A384-1DA6983817CCQ38261014-9D73333C-AA32-41F1-80B5-A633F3FCA73DQ38262105-4BE0D396-07F1-49FF-93C5-B64072902FEBQ38609396-2EA89351-E17E-4261-B8E4-73AF1FE9D43FQ38785733-94B995F9-813C-4029-BFB6-848F4EC7BE96Q39474702-1580DFDC-D779-4BE8-B500-0571191C55B7Q40267201-EF034EBF-B90E-41C1-9E2A-ED3D452CD8DEQ40711796-64B76238-0950-44C2-9FED-FAB6DD0977BDQ40986521-FBD9DC6D-1008-40AD-982B-F793533938CFQ41912848-0C663CC9-48AD-41AA-A89D-952166170908Q42133283-EBD091DE-A6EB-497A-9D84-E00285F4B8BCQ42418585-2BF7E1AC-26B1-476E-B91F-30B70BD3299CQ47102384-BF203C25-C03A-49A3-B7BB-EEA176826B7FQ50447530-A4767DAC-D261-47DA-9B51-B743182B84C4Q52668598-0D839BBE-9BF4-46AE-B37B-0B95E4F21912Q52755792-D32D1318-1BA0-46D0-B763-C9B73F032922Q55260948-084D38EE-BF3E-4520-8DDB-45767CC92AD7Q58793875-A884674B-3C74-41CC-A291-201B76E50CF7
P2860
Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease.
@en
Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease.
@nl
type
label
Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease.
@en
Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease.
@nl
prefLabel
Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease.
@en
Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease.
@nl
P2860
P1476
Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease.
@en
P2093
Kimberly Reidy
P2860
P304
P356
10.1053/J.AJKD.2009.07.003
P577
2009-10-01T00:00:00Z